GRM2 and psychotic disorder: Additionally, the activation of metabotropic glutamate receptor 2 (mGlu2) has been shown to reduce psychosis-like behaviors (PLBs) in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned macaques (Nuara et al., 2021).